{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:32:11Z","timestamp":1786649531968,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This study aimed to determine the recurrence rate and related risk factors of primary fallopian tube cancer (PFTC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective study of 47 patients with histopathological diagnosis of PFTC treated at Tu Du Hospital between January 1, 2015, and July 31, 2022. The cumulative recurrence rate was estimated using the life table method, and recurrence-associated factors were determined using the Log\u2013rank test and Cox proportional hazard model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The median follow-up period was 40 months (range, 7\u201396 months). Eight patients (17.0%) experienced recurrence. The cumulative recurrence rate of PFTC patients at 12 months was 4.4% (95% confidence interval [95% CI]: 1.12\u201316.45), at 24 months was 9.1% (95% CI: 3.52\u201322.5), at 36 months was 14.9% (95% CI: 6.92\u201330.41), at 48 months was 19.3% (95% CI: 9.35\u201337.24), and at 60 months was 25.7% (95% CI: 12.68\u201347.88). A higher recurrence rate was significantly associated with elevated pretreatment CA 125 level (&lt;35 U\/mL vs. \u226535 U\/mL, hazards ratio [HR] = 36.9, 95% CI: 1.47\u2013921.37), advanced FIGO stages (Stage I-II vs. stages III, HR = 6.61, 95% CI: 1.18\u201336.93), and suboptimal debulking surgery (residual disease \u22641 cm vs. residual disease &gt;1 cm, HR = 7.52, 95% CI: 1.47\u201338.49).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The overall recurrence rate of PFTC patients in Southern Vietnam was 17.0%. Appropriate follow-up strategies for patients with high-risk factors are needed for early detection and management of recurrence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/gmit.gmit_110_23","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T04:01:08Z","timestamp":1728446468000},"page":"247-252","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Recurrence Rate and Associated Factors of Primary Fallopian Tube Carcinoma in the South of Vietnam"],"prefix":"10.4103","volume":"13","author":[{"given":"Tuan","family":"Vo","sequence":"first","affiliation":[{"name":"Senior Attending OB-GYN Physician at Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duy","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Resident OB-GYN Physician, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thang","family":"Ho","sequence":"additional","affiliation":[{"name":"Senior Attending OB-GYN Physician at Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang","family":"Tran","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat","family":"Nguyen","sequence":"additional","affiliation":[{"name":"OB-GYN Physician, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuong","family":"Bui","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thinh","family":"Cao","sequence":"additional","affiliation":[{"name":"Senior Attending OB-GYN Physician at Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Vo","sequence":"additional","affiliation":[{"name":"Medical Student of Department of Optometry, University of Houston, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"key":"R1-20260427","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.10970","article-title":"Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953-97","volume":"104","author":"Riska","year":"2003","journal-title":"Int J Cancer"},{"key":"R2-20260427","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ygyno.2018.01.030","article-title":"Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US","volume":"149","author":"Liao","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R3-20260427","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.mpdhp.2008.06.009","article-title":"Recent advances in the understanding of the pathogenesis of serous carcinoma: The concept of low- and high-grade disease and the role of the fallopian tube","volume":"14","author":"Carlson","year":"2008","journal-title":"Diagn Histopathol (Oxf)"},{"key":"R4-20260427","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R5-20260427","first-page":"ijgc-2022-003468","article-title":"Retrospective study of histopathological and prognostic characteristics of primary fallopian tube carcinomas: Twenty year experience (SOCRATE)","author":"Borghese","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R6-20260427","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tjog.2014.07.003","article-title":"Primary fallopian tube cancer: Domestic data and up-to-date review","volume":"53","author":"Horng","year":"2014","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R7-20260427","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jcma.2013.06.010","article-title":"Primary fallopian tube carcinoma: A clinicopathologic analysis and literature review","volume":"76","author":"Lau","year":"2013","journal-title":"J Chin Med Assoc"},{"key":"R8-20260427","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.21037\/apm-21-2083","article-title":"Long-term follow-up of 46 cases of primary fallopian tube carcinoma: A single institute study","volume":"10","author":"Li","year":"2021","journal-title":"Ann Palliat Med"},{"key":"R9-20260427","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ijgo.13497","article-title":"Clinical characteristics of primary Fallopian tube carcinoma: A single-institution retrospective study of 57 cases","volume":"153","author":"Ma","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"R10-20260427","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/jog.15293","article-title":"HE4 is associated with clinical risk prognostic factors and survival outcome in primary fallopian tube carcinoma patients","volume":"48","author":"Mi","year":"2022","journal-title":"J Obstet Gynaecol Res"},{"key":"R11-20260427","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1634\/theoncologist.11-8-902","article-title":"Fallopian tube carcinoma: A review","volume":"11","author":"Pectasides","year":"2006","journal-title":"Oncologist"},{"key":"R12-20260427","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0039-6109(16)41439-8","article-title":"Carcinoma of the fallopian tube","volume":"58","author":"Sedlis","year":"1978","journal-title":"Surg Clin North Am"},{"key":"R13-20260427","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","article-title":"Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the gynecological cancer intergroup (GCIG)","volume":"21","author":"Rustin","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R14-20260427","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejogrb.2013.03.023","article-title":"Primary fallopian tube carcinoma","volume":"169","author":"Kalampokas","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R15-20260427","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.anndiagpath.2012.10.001","article-title":"Carcinoma of the fallopian tube: Results of a multi-institutional retrospective analysis of 127 patients with evaluation of staging and prognostic factors","volume":"17","author":"Alvarado-Cabrero","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"R16-20260427","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/1097-0142(20001001)89:7<1555::AID-CNCR20>3.0.CO;2-J","article-title":"The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: A multicenter study","volume":"89","author":"Hefler","year":"2000","journal-title":"Cancer"},{"key":"R17-20260427","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/IGC.0b013e318220fc46","article-title":"A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival","volume":"21","author":"Shamshirsaz","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R18-20260427","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/1097-0142(20001115)89:10<2076::AID-CNCR7>3.0.CO;2-V","article-title":"Carcinoma of the fallopian tube","volume":"89","author":"Baekelandt","year":"2000","journal-title":"Cancer"},{"key":"R19-20260427","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/IGC.0000000000000648","article-title":"Primary fallopian tube carcinoma: A single-institution experience of 101 cases: A retrospective study","volume":"26","author":"Bao","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R20-20260427","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1620\/tjem.218.5","article-title":"Systematic lymphadenectomy improves survival in patients with advanced-stage primary fallopian tube cancer","volume":"218","author":"Kim","year":"2009","journal-title":"Tohoku J Exp Med"},{"key":"R21-20260427","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4143\/crt.2014.058","article-title":"Prognostic significance of retroperitoneal lymphadenectomy, preoperative neutrophil lymphocyte ratio and platelet lymphocyte ratio in primary fallopian tube carcinoma: A multicenter study","volume":"47","author":"Gungorduk","year":"2015","journal-title":"Cancer Res Treat"}],"container-title":["Gynecology and Minimally Invasive Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/gmit.gmit_110_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:55:05Z","timestamp":1786647305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/gmit.gmit_110_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/gmit.gmit_110_23","relation":{},"ISSN":["2213-3070","2213-3089"],"issn-type":[{"value":"2213-3070","type":"print"},{"value":"2213-3089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,7]]},"assertion":[{"value":"2023-09-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}